{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:37:11Z","timestamp":1793407031116,"version":"4.5.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Colorectal cancer (CRC) can compromise the mucosal barrier and subsequently allow a route for bacterial invasion into the portal system or systemic circulation. Despite preliminary data suggesting that patients who experienced pyogenic liver abscess (PLA) have higher CRC incidence rates, data from outside the Southeast Asian population are sparse.<\/jats:p><\/jats:sec>Objective<\/jats:title>To investigate whether there is an association between PLA and the subsequent incidence of diagnosed CRC using the Veterans Health Administration (VHA) cohort.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>A patient-level matched retrospective cohort study was conducted at 127 VHA hospitals across the US from January 1, 2003, to December 31, 2020. Patients were followed up to 10 years from PLA diagnosis. Data analysis was performed from April 14, 2002, to October 31, 2023. All patients who were admitted to VHA hospitals with a diagnosis of PLA were included. For each patient with PLA, up to 3 controls without diagnosis of PLA, matching age, sex, and health care facility, were selected.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Pyogenic liver abscess.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was CRC diagnosis during the follow-up period. A multivariable Fine-Gray subdistribution regression model with time-dependent coefficient was used to estimate the time-varying hazard ratio (HR) of CRC incidence while accounting for mortality as a competing event.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 8286 patients with PLA (male, 96.5%; mean [SD] age, 65.8 [11.9] years) and 23\u202f201 patient-level matched controls (male, 96.3%; mean age, 65.3 [11.7] years) were included. A diagnosis of CRC was found in a significantly higher proportion of patients with PLA compared with controls (1.9% [159 of 8286] vs 0.8% [196 of 23\u202f201]; P<\/jats:italic>\u2009&amp;lt;\u2009.001). The incidence of CRC was significantly higher among patients with PLA during the first 3 years from PLA diagnosis (HR, 3.64; 95% CI, 2.70-4.91 at 0.5 years; HR, 2.51; 95% CI, 1.93-3.26 at 1 year; HR, 1.74; 95% CI, 1.33-2.28 at 2 years; and HR, 1.41; 95% CI, 1.05-1.89 at 3 years), but not significant after 3 years. This association was not observed among patients whose PLA was likely secondary to cholangitis or cholecystitis (HR, 1.78; 95% CI, 0.89-3.56 at 0.5 years).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this patient-level matched retrospective cohort study, a significantly higher incidence of CRC was observed up to 3 years from PLA diagnosis. The findings suggest that offering CRC screening for patients with cryptogenic PLA may be useful, especially patients who have not been screened according to guidelines.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.48218","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T16:01:14Z","timestamp":1702915274000},"page":"e2348218","source":"Crossref","is-referenced-by-count":17,"title":["Incidence of Colorectal Cancer in Patients Diagnosed With Pyogenic Liver Abscess"],"prefix":"10.1001","volume":"6","author":[{"given":"Hiroyuki","family":"Suzuki","sequence":"first","affiliation":[{"name":"Center for Access & Delivery Research & Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa"},{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Kidder","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Internal Medicine, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Center for Access & Delivery Research & Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa"},{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiko","family":"Goto","sequence":"additional","affiliation":[{"name":"Center for Access & Delivery Research & Evaluation, Iowa City Veterans Affairs Health Care System, Iowa City, Iowa"},{"name":"Division of Infectious Diseases, Department of Internal Medicine, University of Iowa, Iowa City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"issue":"17","key":"zoi231405r2","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2208375","article-title":"Effect of colonoscopy screening on risks of colorectal cancer and related death.","volume":"387","author":"Bretthauer","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi231405r3","doi-asserted-by":"publisher","first-page":"458","DOI":"10.14309\/ajg.0000000000001122","article-title":"ACG Clinical Guidelines: colorectal cancer screening 2021.","volume":"116","author":"Shaukat","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"zoi231405r5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.7326\/M19-0642","article-title":"Screening for colorectal cancer in asymptomatic average-risk adults: a guidance statement from the American College of Physicians.","volume":"171","author":"Qaseem","year":"2019","journal-title":"Ann Intern Med"},{"key":"zoi231405r6","first-page":"1","article-title":"Early detection for colorectal cancer: ASCO resource-stratified guideline.","volume":"5","author":"Lopes","year":"2019","journal-title":"J Glob Oncol"},{"issue":"8","key":"zoi231405r7","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1056\/NEJMc2112409","article-title":"Association between improved colorectal screening and racial disparities.","volume":"386","author":"Doubeni","year":"2022","journal-title":"N Engl J Med"},{"issue":"10","key":"zoi231405r9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.15585\/mmwr.mm6910a1","article-title":"Vital signs: colorectal cancer screening test use\u2014United States, 2018.","volume":"69","author":"Joseph","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"zoi231405r10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1001\/archsurg.1989.01410050051009","article-title":"Liver abscess: the need for complete gastrointestinal evaluation.","volume":"124","author":"Cohen","year":"1989","journal-title":"Arch Surg"},{"issue":"9","key":"zoi231405r11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/cid\/cir609","article-title":"Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis.","volume":"53","author":"Boleij","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"10","key":"zoi231405r12","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1093\/cid\/ciac259","article-title":"Bacteremia with anaerobic bacteria and association with colorectal cancer: a population-based cohort study.","volume":"75","author":"Justesen","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"2","key":"zoi231405r13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/j.gastro.2018.04.028","article-title":"Association between bacteremia from specific microbes and subsequent diagnosis of colorectal cancer.","volume":"155","author":"Kwong","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"zoi231405r14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1053\/j.gastro.2013.09.058","article-title":"Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study.","volume":"146","author":"Lai","year":"2014","journal-title":"Gastroenterology"},{"issue":"12","key":"zoi231405r15","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.dld.2019.08.016","article-title":"Prevalence of colorectal cancer in cryptogenic pyogenic liver abscess patients: do they need screening colonoscopy? a systematic review and meta-analysis.","volume":"51","author":"Mohan","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"6","key":"zoi231405r16","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.jamcollsurg.2010.03.004","article-title":"Current management of pyogenic liver abscess: surgery is now second-line treatment.","volume":"210","author":"Mezhir","year":"2010","journal-title":"J Am Coll Surg"},{"issue":"4","key":"zoi231405r17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study.","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"issue":"9596","key":"zoi231405r18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"zoi231405r21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12874-019-0824-7","article-title":"Validation of diagnosis codes to identify side of colon in an electronic health record registry.","volume":"19","author":"Luhn","year":"2019","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"zoi231405r22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12913-023-09266-1","article-title":"Validation of algorithms to identify colorectal cancer patients from administrative claims data of a Japanese hospital.","volume":"23","author":"Hirano","year":"2023","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"zoi231405r23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020630","article-title":"Accuracy of colorectal cancer ICD-9-CM codes in Italian administrative healthcare databases: a cross-sectional diagnostic study.","volume":"8","author":"Cozzolino","year":"2018","journal-title":"BMJ Open"},{"key":"zoi231405r24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1478-7954-4-2","article-title":"Accuracy and completeness of mortality data in the Department of Veterans Affairs.","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metr"},{"issue":"3","key":"zoi231405r25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1161\/CIRCOUTCOMES.115.001841","article-title":"Semi-competing risks data analysis: accounting for death as a competing risk when the outcome of interest is nonterminal.","volume":"9","author":"Haneuse","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"zoi231405r26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks.","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"zoi231405r27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-2288-10-20","article-title":"Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer.","volume":"10","author":"Bellera","year":"2010","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"zoi231405r28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/sim.v30.3","article-title":"Analysis of multilevel grouped survival data with time-varying regression coefficients.","volume":"30","author":"Wong","year":"2011","journal-title":"Stat Med"},{"issue":"2","key":"zoi231405r29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/jgh.2012.27.issue-2","article-title":"Cryptogenic pyogenic liver abscess as the herald of colon cancer.","volume":"27","author":"Jeong","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"23","key":"zoi231405r30","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3748\/wjg.v18.i23.2948","article-title":"Pyogenic liver abscesses associated with nonmetastatic colorectal cancers: an increasing problem in Eastern Asia.","volume":"18","author":"Qu","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"12","key":"zoi231405r31","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1111\/codi.2012.14.issue-12","article-title":"Higher rate of colorectal cancer among patients with pyogenic liver abscess with Klebsiella pneumoniae than those without: an 11-year follow-up study.","volume":"14","author":"Huang","year":"2012","journal-title":"Colorectal Dis"},{"issue":"1","key":"zoi231405r32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/ajg.2009.614","article-title":"A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends.","volume":"105","author":"Meddings","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"zoi231405r33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.22269","article-title":"Utilization of a colorectal cancer screening test among individuals with average risk.","volume":"4","author":"Fisher","year":"2021","journal-title":"JAMA Netw Open"},{"key":"zoi231405r1","unstructured":"Colorectal Cancer Alliance. Know the facts. Colorectal cancer. Accessed May 30, 2023. https:\/\/www.ccalliance.org\/colorectal-cancer-information\/facts-and-statistics"},{"key":"zoi231405r4","unstructured":"US Preventive Services Task Force. Colorectal cancer: screening. May 18, 2021. Accessed May 2, 2023. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/colorectal-cancer-screening"},{"key":"zoi231405r8","unstructured":"Centers for Disease Control and Prevention. Adults who have never been screened for colorectal cancer: Behavioral Risk Factor Surveillance System, 2012 and 2020. Accessed November 12, 2023. https:\/\/www.cdc.gov\/pcd\/issues\/2022\/22_0001.htm?"},{"key":"zoi231405r19","unstructured":"US Department of Veterans Affairs. Alcohol Use Disorders Identification Test. Alcoholic liver disease. Accessed October 15, 2023. https:\/\/www.hepatitis.va.gov\/alcohol\/treatment\/audit-c.asp"},{"key":"zoi231405r20","unstructured":"Centers for Disease Control and Prevention. Agency for Toxic Substances and Disease Registry. CDC\/ATSDR SVI Data and Documentation Download. Accessed October 15, 2023. https:\/\/www.atsdr.cdc.gov\/placeandhealth\/svi\/data_documentation_download.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2812893\/suzuki_2023_oi_231405_1701969049.41225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T16:01:22Z","timestamp":1702915282000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2812893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.48218","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]}}}